ISRCTN ISRCTN33354155
DOI https://doi.org/10.1186/ISRCTN33354155
Secondary identifying numbers Protocol version 2
Submission date
28/06/2007
Registration date
17/09/2007
Last edited
12/01/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr Matthew Costa
Scientific

Associate Professor Trauma and Orthopaedics Warwick Medical School
Clinical Sciences Research Institute
Clifford Bridge Road
Coventry
CV2 2DX
United Kingdom

Phone +44 (0)2476 968618
Email Matthew.Costa@warwick.ac.uk

Study information

Study designRandomised single blind controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleThe Warwick Arthroplasty Trial: a randomised controlled trial of total hip arthroplasty versus resurfacing hip arthroplasty in the treatment of young patients with arthritis of the hip joint
Study acronymWAT
Study objectivesThere is no difference in hip function in patients with severe arthritis of the hip joint who have undergone a total hip arthroplasty or a resurfacing arthroplasty at one year post-operation.
Ethics approval(s)Approval received from the Coventry Research Ethics Committee on the 9th May 2007 (ref: 07/Q2802/26).
Health condition(s) or problem(s) studiedOsteoarthritis of the hip joint
Intervention1. Patients in the Total Hip Arthroplasty group will have the head of their femur removed and replaced with a prosthetic component fixed inside the femoral shaft
2. Patients in the Hip Resurfacing Arthroplasty group will have a resurfacing ‘cap’ placed upon their existing femoral head

Both groups will have a new acetabular (socket) component. The details of both operative procedures will be left to the discretion of the surgeon to increase generalisabilty of the result. All patients will receive standardised rehabilitation after the operation. As part of the research patients will be followed-up for one year post-operation.

Joint sponsor of this trial:
University of Warwick (UK)
c/o Donna McIntyre, Grants and Contracts Officer
Research Support Services
University House, Kirby Corner Road
Coventry CV4 8UW
United Kingdom
Tel: +44 (0)2476 522989
Email: D.McIntyre@warwick.ac.uk
Intervention typeOther
Primary outcome measure1. Harris Hip Score, measured at pre-operation and 6, 12, 26 and 52 weeks post-operation
2. Oxford Hip Score, measured at pre-operation and 6, 12, 26 and 52 weeks post-operation
Secondary outcome measuresAll secondary outcomes will be measured at pre-operation and 6, 12, 26 and 52 weeks post-operation:
1. Disability Rating Index
2. Physical activity level
3. Complication rate
4. Quality of life
5. Health economic evaluation
Overall study start date01/06/2007
Completion date31/05/2010

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants172
Total final enrolment126
Key inclusion criteria1. Over the age of 18
2. Able to give informed consent
3. Eligible for hip resurfacing arthroplasty
Key exclusion criteriaPatients with a concomitant medical problem that will preclude operation.
Date of first enrolment01/06/2007
Date of final enrolment31/05/2010

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Associate Professor Trauma and Orthopaedics Warwick Medical School
Coventry
CV2 2DX
United Kingdom

Sponsor information

University Hospitals Coventry and Warwickshire NHS Trust (UK)
Hospital/treatment centre

c/o Ceri Jones
Research and Development Department
Clifford Bridge Road
Coventry
CV2 2DX
England
United Kingdom

Phone +44 (0)2476 966196
Email Ceri.jones@UHCW.nhs.uk
Website http://www.uhcw.nhs.uk/
ROR logo "ROR" https://ror.org/025n38288

Funders

Funder type

Government

National Institute of Health Research (UK) - under the Research for Patient Benefit scheme (ref number: PB-PG-0706-10080)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing planNot provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article 14/01/2010 Yes No
Results article 1-year results 19/04/2012 Yes No
Results article 5-year results 12/03/2018 Yes No

Editorial Notes

12/01/2023: The final enrolment number has been added.
27/09/2018: publication reference added.